Deciphering lactate metabolism in colorectal cancer: Prognostic modeling, immune infiltration, and gene mutation insights

Figure 6 Sensitivity to small molecule drugs. A: Half-maximal inhibitory concentration (IC₅₀) of AZD6482 in the high- and low-risk score groups; B: IC₅₀ of tozasertib in the high- and low-risk score groups; C: IC₅₀ of SB216763 in the high- and low-risk score groups. ^aP < 0.05, ^dP < 0.0001, denote significant difference from the low-risk score groups. IC₅₀: Half-maximal inhibitory concentration.